Vanguard Group Inc Context Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,502,198 shares of CNTX stock, worth $9.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,502,198
Previous 598,303
652.49%
Holding current value
$9.59 Million
Previous $825,000
991.39%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CNTX
# of Institutions
38Shares Held
57.2MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT7.42MShares$15.8 Million0.49% of portfolio
-
Great Point Partners LLC Greenwich, CT7.42MShares$15.8 Million3.93% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$15.8 Million0.73% of portfolio
-
Nextech Invest Ag7.42MShares$15.8 Million2.8% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.16MShares$11 Million4.29% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $34M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...